ELX-02 Reduces Sweat Chloride in Patients with G542X Mutation. Trials FindEloxx PharmaceuticalsҠexperimental therapy ELX-02 was generally safe and resulted in a significant reduction in sweat chloride levels נa biomarker..#Cystic Fibrosis·disorders.solutions·Nov 21, 2021ELX-02 Reduces Sweat Chloride in Patients with G542X Mutation. Trials Find